Suggestions
Aiman Shalabi
Vice President R&D, Cell and Gene Therapies (NYESO) at GlaxoSmithKline
Aiman Shalabi is the Vice President of Research and Development for Cell and Gene Therapies at GlaxoSmithKline Pharma GmbH (GSK). He holds a PharmD and an MBA, which complement his expertise in the pharmaceutical industry, particularly in oncology and innovative therapies.
In his role at GSK, Aiman focuses on advancing personalized medicine through cell therapy, utilizing the body's own immune system to combat diseases like cancer. His work involves overseeing the development and implementation of cutting-edge therapies that aim to improve patient outcomes.
Aiman is active on LinkedIn, where he shares insights related to oncology and cell therapy advancements, reflecting his commitment to innovation in the healthcare sector. His professional background emphasizes a blend of clinical knowledge and business acumen, making him a key figure in the field of pharmaceutical research and development.
